Regulation of insulin secretion: a matter of phase control and amplitude modulation

J C Henquin, J C Henquin

Abstract

The consensus model of stimulus-secretion coupling in beta cells attributes glucose-induced insulin secretion to a sequence of events involving acceleration of metabolism, closure of ATP-sensitive K(+) channels, depolarisation, influx of Ca(2+) and a rise in cytosolic free Ca(2+) concentration ([Ca(2+)](c)). This triggering pathway is essential, but would not be very efficient if glucose did not also activate a metabolic amplifying pathway that does not raise [Ca(2+)](c) further but augments the action of triggering Ca(2+) on exocytosis. This review discusses how both pathways interact to achieve temporal control and amplitude modulation of biphasic insulin secretion. First-phase insulin secretion is triggered by the rise in [Ca(2+)](c) that occurs synchronously in all beta cells of every islet in response to a sudden increase in the glucose concentration. Its time course and duration are shaped by those of the Ca(2+) signal, and its amplitude is modulated by the magnitude of the [Ca(2+)](c) rise and, substantially, by amplifying mechanisms. During the second phase, synchronous [Ca(2+)](c) oscillations in all beta cells of an individual islet induce pulsatile insulin secretion, but these features of the signal and response are dampened in groups of intrinsically asynchronous islets. Glucose has hardly any influence on the amplitude of [Ca(2+)](c) oscillations and mainly controls the time course of triggering signal. Amplitude modulation of insulin secretion pulses largely depends on the amplifying pathway. There are more similarities than differences between the two phases of glucose-induced insulin secretion. Both are subject to the same dual, hierarchical control over time and amplitude by triggering and amplifying pathways, suggesting that the second phase is a sequence of iterations of the first phase.

References

    1. Biophys J. 2008 Sep;95(5):2226-41
    1. Am J Physiol. 1989 Aug;257(2 Pt 1):E241-6
    1. Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):451-63
    1. Diabetes. 1993 May;42(5):670-4
    1. J Clin Endocrinol Metab. 2002 Jan;87(1):213-21
    1. Diabetes. 1998 Aug;47(8):1266-73
    1. J Biol Chem. 2002 Sep 6;277(36):32883-91
    1. Diabetes. 2002 Feb;51 Suppl 1:S53-9
    1. J Physiol. 2006 Apr 15;572(Pt 2):379-92
    1. Eur J Clin Invest. 2003 Sep;33(9):742-50
    1. J Biol Chem. 1996 Feb 16;271(7):3647-51
    1. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E143-E148
    1. Diabetes. 2006 Dec;55(12):3470-7
    1. Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E340-7
    1. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1287-97
    1. Diabetes. 2000 Mar;49(3):424-30
    1. Diabetes. 2004 Dec;53 Suppl 3:S48-58
    1. Diabetes. 2004 Dec;53 Suppl 3:S113-22
    1. Biochem J. 1994 Feb 1;297 ( Pt 3):455-61
    1. Diabetologia. 1987 Aug;30(8):659-65
    1. FEBS Lett. 1998 Jan 9;421(2):115-9
    1. Diabetes. 2005 Jun;54(6):1798-807
    1. Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E890-900
    1. Am J Physiol. 1996 Oct;271(4 Pt 1):E702-10
    1. Diabetes. 1992 Jul;41(7):777-81
    1. J Cell Biol. 2007 May 21;177(4):695-705
    1. Endocrinology. 2009 Jan;150(1):33-45
    1. J Biol Chem. 2007 Jan 19;282(3):1747-56
    1. J Clin Invest. 1993 Mar;91(3):871-80
    1. Nature. 2006 Mar 23;440(7083):470-6
    1. Br J Pharmacol. 2001 Jun;133(4):575-85
    1. Eur J Endocrinol. 2001 Jun;144(6):667-75
    1. Cell Metab. 2008 Jul;8(1):26-37
    1. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E828-33
    1. Am J Physiol. 1963 Oct;205:638-44
    1. FEBS Lett. 2002 Oct 23;530(1-3):215-9
    1. Diabetes. 2002 Feb;51 Suppl 1:S144-51
    1. Diabetes. 1999 Dec;48(12):2374-82
    1. Diabetes. 1998 May;47(5):758-63
    1. Diabetes. 2005 Jul;54(7):2132-42
    1. J Physiol. 1997 Sep 1;503 ( Pt 2):399-412
    1. Diabetologia. 2003 Aug;46(8):1029-45
    1. Endocrinology. 1968 Sep;83(3):572-84
    1. Naunyn Schmiedebergs Arch Pharmacol. 1988 Oct;338(4):459-62
    1. Diabetes. 2004 Dec;53 Suppl 3:S104-12
    1. J Clin Invest. 1992 Apr;89(4):1288-95
    1. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10402-6
    1. Am J Physiol. 1980 May;238(5):R378-89
    1. Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E540-9
    1. Diabetes. 2001 Mar;50(3):540-50
    1. Diabetologia. 2003 Jul;46(7):875-91
    1. J Clin Invest. 2005 Jan;115(1):146-54
    1. Nature. 1968 Jul 27;219(5152):389-90
    1. Diabetes. 2000 Nov;49(11):1751-60
    1. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):760-5
    1. Am J Med. 1981 Mar;70(3):579-88
    1. Biochem J. 1964 Oct;93(1):66-78
    1. Diabetes. 2002 Feb;51 Suppl 1:S162-70
    1. Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E523-9
    1. Diabetes. 2002 Feb;51 Suppl 1:S177-82
    1. Biochem Biophys Res Commun. 1988 Oct 31;156(2):769-75
    1. Nature. 2001 Dec 13;414(6865):807-12
    1. Endocr J. 2001 Jun;48(3):275-88
    1. Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E396-409
    1. Diabetes. 2002 Feb;51 Suppl 1:S152-61
    1. Diabetes Obes Metab. 2007 Nov;9 Suppl 2:118-32
    1. Diabetes. 2000 Mar;49(3):311-8
    1. Traffic. 2008 Jul;9(7):1191-203
    1. Diabetologia. 2002 Jan;45(1):3-20
    1. Endocrinology. 1995 Dec;136(12):5725-30
    1. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10728-32
    1. Neuron. 2002 Jan 17;33(2):287-99
    1. J Biol Chem. 1991 May 15;266(14):9314-9
    1. J Biol Chem. 2006 Aug 4;281(31):22142-22151
    1. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1279-86
    1. J Biol Chem. 2004 Jul 30;279(31):32316-24
    1. Diabetes. 2005 Nov;54(11):3073-81
    1. J Biol Chem. 1996 Aug 23;271(34):20559-65
    1. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19333-8
    1. Eur J Biochem. 1999 Jan;259(1-2):3-17
    1. Pflugers Arch. 1991 May;418(4):417-22
    1. Nature. 1976 Aug 5;262(5568):502-4
    1. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):41-9
    1. Diabetes. 2006 Feb;55(2):441-51
    1. Diabetologia. 2008 Jan;51(1):101-9
    1. Diabetes. 1992 Apr;41(4):438-43
    1. Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E138-54
    1. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):58-72
    1. Diabetes. 2002 Feb;51 Suppl 1:S60-7
    1. J Cell Sci. 2002 Nov 1;115(Pt 21):4177-89
    1. Biochem Biophys Res Commun. 2000 Jan 7;267(1):179-83
    1. Diabetes Metab. 2007 Dec;33(6):430-8
    1. Biol Chem. 2008 Mar;389(3):305-12
    1. Experientia. 1984 Oct 15;40(10):1043-52
    1. Acta Endocrinol (Copenh). 1967 Jun;55(2):278-304
    1. J Biol Chem. 2000 Mar 31;275(13):9270-7
    1. Biophys J. 2006 Sep 15;91(6):2082-96
    1. Prog Biophys Mol Biol. 1989;54(2):87-143

Source: PubMed

3
Sottoscrivi